newscontact us

ThermoGenesis Corp. Stockholders Approve Acquisition of TotipotentRX

ThermoGenesis to Change Name to Cesca Therapeutics

RANCHO CORDOVA, Calif., Feb. 13, 2014 (GLOBE NEWSWIRE) — ThermoGenesis Corp. (Nasdaq:KOOL) (“ThermoGenesis”), a leading supplier of enabling technologies for the processing and storage of stem cells and other biological tissues, reported today that it received stockholder approval at a special meeting of the stockholders for the acquisition of TotipotentRX through a merger into ThermoGenesis. Incident to the acquisition, ThermoGenesis will also change its corporate name to Cesca Therapeutics Inc., which stands for Clinical Excellence in Stem Cell Applications.

021314 Cesca Merger Approval Press Release Final